BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 2120589)

  • 1. Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors--an assessment of the efficacy of testing in donor screening. The HIV-Antigen Study Group.
    Alter HJ; Epstein JS; Swenson SG; VanRaden MJ; Ward JW; Kaslow RA; Menitove JE; Klein HG; Sandler SG; Sayers MH
    N Engl J Med; 1990 Nov; 323(19):1312-7. PubMed ID: 2120589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type 1. The Transfusion Safety Study Group.
    Busch MP; Taylor PE; Lenes BA; Kleinman SH; Stuart M; Stevens CE; Tomasulo PA; Allain JP; Hollingsworth CG; Mosley JW
    N Engl J Med; 1990 Nov; 323(19):1308-12. PubMed ID: 2120588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion-associated human immunodeficiency virus type 1 from screened antibody-negative blood donors.
    Roberts CR; Longfield JN; Platte RC; Zielmanski KP; Wages J; Fowler A
    Arch Pathol Lab Med; 1994 Dec; 118(12):1188-92. PubMed ID: 7979912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma viremia in human immunodeficiency virus infection.
    Coombs RW; Collier AC; Allain JP; Nikora B; Leuther M; Gjerset GF; Corey L
    N Engl J Med; 1989 Dec; 321(24):1626-31. PubMed ID: 2511447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
    Stramer SL; Glynn SA; Kleinman SH; Strong DM; Caglioti S; Wright DJ; Dodd RY; Busch MP;
    N Engl J Med; 2004 Aug; 351(8):760-8. PubMed ID: 15317889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated rate of HIV-1-infectious but seronegative blood donations in Bangkok, Thailand.
    Kitayaporn D; Kaewkungwal J; Bejrachandra S; Rungroung E; Chandanayingyong D; Mastro TD
    AIDS; 1996 Sep; 10(10):1157-62. PubMed ID: 8874634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dynamics of the antibody response and p24 antigenemia in HIV-1 infected individuals in Czechoslovakia].
    Kopecká D; Brůcková M; Stanková M; Syrůcek L; Vojtĕchovský K; Petkov V
    Cesk Epidemiol Mikrobiol Imunol; 1990 Mar; 39(2):65-73. PubMed ID: 2142624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p24 antigen screening to reduce the risk of HIV transmission by seronegative bone allograft donors.
    Malhotra R; Morgan DA
    Natl Med J India; 2000; 13(4):190-2. PubMed ID: 11002686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infectious disease markers in blood donors in northern Thailand.
    Mundee Y; Kamtorn N; Chaiyaphruk S; Nantachit N; Ness PM; Nelson KE
    Transfusion; 1995 Mar; 35(3):264-7. PubMed ID: 7878721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
    Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
    Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HIV antigen test of blood donors].
    Knödler B; Kühnl P
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():10-1. PubMed ID: 8374280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first-time blood donors in São Paulo, Brazil.
    Barreto CC; Sabino EC; Gonçalez TT; Laycock ME; Pappalardo BL; Salles NA; Wright DJ; Chamone DF; Busch MP
    Transfusion; 2005 Nov; 45(11):1709-14. PubMed ID: 16271094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China.
    Shang G; Yan Y; Yang B; Shao C; Wang F; Li Q; Seed CR
    Transfus Apher Sci; 2009 Aug; 41(1):3-7. PubMed ID: 19487161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. U.S. Public Health Service guidelines for testing and counseling blood and plasma donors for human immunodeficiency virus type 1 antigen.
    MMWR Recomm Rep; 1996 Mar; 45(RR-2):1-9. PubMed ID: 8604210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of human immunodeficiency virus infection in high-risk individuals seronegative by first generation enzyme-linked immunosorbent assay.
    Pedersen C; Lindhardt BO; Lauritzen E; Gaub J; Dickmeiss E
    Dan Med Bull; 1989 Oct; 36(5):490-1. PubMed ID: 2509148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of HIV infection in blood donors with indeterminate western blot tests for antibody to HIV-1.
    Jackson JB; MacDonald KL; Cadwell J; Sullivan C; Kline WE; Hanson M; Sannerud KJ; Stramer SL; Fildes NJ; Kwok SY
    N Engl J Med; 1990 Jan; 322(4):217-22. PubMed ID: 2403658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [AIDS and blood transfusion].
    Baumgarten K
    Z Hautkr; 1990 Jul; 65(7):677-80, 683. PubMed ID: 2399757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of testing for human immunodeficiency virus.
    Bylund DJ; Ziegner UH; Hooper DG
    Clin Lab Med; 1992 Jun; 12(2):305-33. PubMed ID: 1611822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.
    Nübling CM; Chudy M; Volkers P; Löwer J
    Transfusion; 2006 Nov; 46(11):1886-91. PubMed ID: 17076842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of virus isolation, polymerase chain reaction and antigen detection in children of mothers infected with immunodeficiency virus.
    Dis Markers; 1990; 8(4):228. PubMed ID: 2128474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.